Vaccine production us9/22/2023 ![]() “This is about assuring expanded capacity against Covid variants and also preparing for the next pandemic,” Dr. That could include building new plants or production lines, and it might require licensing technology from other vaccine manufacturers. ![]() David Kessler, who oversees vaccine distribution as the chief science officer for the Covid-19 response, said the intent is to invest in companies with experience making mRNA vaccines, enabling those companies to expand production to meet the government’s needs. In interviews, Jeff Zients, President Biden’s coronavirus response coordinator, and Dr. The Biden administration severed its relationship with Emergent earlier this month.Īdministration officials insist this plan will be different. Until recently, the federal government had a manufacturing partnership with Emergent BioSolutions, whose Baltimore facility ruined millions of doses of Johnson & Johnson’s coronavirus vaccine earlier this year. In many poor nations, including those struggling to combat other diseases like tuberculosis, malaria and H.I.V., even health care workers on the front lines of the pandemic remain unvaccinated.Įxpanding vaccine manufacturing through public-private alliances is not without risks. Less than 10 percent of Africa’s population is vaccinated, she said, compared with more than 50 percent in North America and Europe. Testifying on Capitol Hill on Wednesday, Loyce Pace, the director of global affairs at the Department of Health and Human Services, said that more than half of the world’s five million coronavirus deaths had occurred in low- and middle-income countries, and that vaccination rates in some of them “are in the single digits.” But national self-interest is also at work as long as vaccination rates remain low in other parts of the world, allowing the virus to spread, dangerous new variants could arise and plunge the United States into crisis once again. President Biden has pledged to fight the coronavirus pandemic by making the United States the “arsenal of vaccines” for the world. ![]() In another development that the White House hopes will reassure the public, the Food and Drug Administration is likely to approve requests from Pfizer-BioNTech and Moderna to offer booster shots to everyone 18 and older. Taken together, the moves amount to an expansive new effort to control the pandemic at a time when Americans are desperate for normalcy and caseloads are creeping up with winter’s approach. ![]() It comes on top of recent decisions to buy enough of Pfizer’s new Covid-19 pill for about 10 million courses of treatment, and to spend $3 billion on rapid over-the-counter tests, which are needed to detect the virus early enough for the Pfizer drug to work. The investment is part of a new plan, announced Wednesday by White House officials, for the government to partner with industry to address immediate vaccine needs in the United States and overseas and to prepare for future pandemics. WASHINGTON - The Biden administration, under pressure to increase the supply of coronavirus vaccines to poor nations, plans to spend billions of dollars to expand manufacturing capacity, with the goal of producing at least one billion additional doses a year beginning in the second half of 2022. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |